Insider · CIK 0001490283

Young Richard A

Reports to the SEC for 4 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001490283

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-03	CAMPCamp4 Therapeutics CorpP Purchase	Director	PPurchase	+16.4K sh	$1.65	+$27K	186,388
2026-06-10	CAMPCamp4 Therapeutics Corp · Stock Option (Right to Buy)A Award	Director	AAward	+28K sh	—	—	28,000
2025-09-11	CAMPCamp4 Therapeutics CorpP Purchase	Director	PPurchase	+15.2K sh	$1.65	+$25K	170,010
2025-06-25	CAMPCamp4 Therapeutics Corp · Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2024-10-15	CAMPCamp4 Therapeutics CorpC Conversion	Director	CConversion	+8,917 sh	—	—	154,859
2024-10-15	CAMPCamp4 Therapeutics Corp · Series A Prime Preferred StockC Conversion	Director	CConversion	−100K sh	—	—	0
2024-09-16	Syros Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,667 sh	—	—	10,667
2024-09-16	Syros Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,667 sh	—	—	2,667
2024-06-28	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−34.8K sh	$5.12	−$178K	8,000
2024-06-20	Omega Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2024-06-05	Syros Pharmaceuticals, Inc.A Award	Director	AAward	+4,000 sh	—	—	42,837
2024-06-05	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2023-09-16	Syros Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,666 sh	—	—	38,837
2023-09-16	Syros Pharmaceuticals, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,666 sh	—	—	5,334
2023-06-07	Omega Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+18.1K sh	—	—	18,118
2023-06-02	Omega Therapeutics, Inc.S Sale	Director	SSale	−5,000 sh	$8.00	−$40K	739,118
2023-06-01	Syros Pharmaceuticals, Inc.A Award	Director	AAward	+4,000 sh	—	—	36,171
2023-06-01	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2023-05-01	Omega Therapeutics, Inc.S Sale	Director	SSale	−5,000 sh	$8.00	−$40K	744,118
2023-04-06	Omega Therapeutics, Inc.S Sale	Director	SSale	−5,000 sh	$8.00	−$40K	749,118
2023-03-17	Omega Therapeutics, Inc.S Sale	Director	SSale	−10K sh	$8.00	−$80K	754,118
2023-01-10	Omega Therapeutics, Inc.S Sale	Director	SSale	−20K sh	$8.00	−$160K	764,118
2022-09-16	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2022-09-16	Syros Pharmaceuticals, Inc.Restricted Stock UnitsA Award	Director	AAward	+8,000 sh	—	—	8,000
2022-09-14	Omega Therapeutics, Inc.S Sale	Director	SSale	−10K sh	$8.00	−$80K	784,118
2022-06-08	Omega Therapeutics, Inc.Option (Right to Buy)A Award	Director	AAward	+18.1K sh	—	—	18,118
2022-06-01	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2021-06-08	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2021-02-16	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−3,750 sh	$12.05	−$45.2K	321,711
2021-02-08	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−3,750 sh	$13.04	−$48.9K	325,461
2020-11-17	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−5,357 sh	$8.75	−$46.9K	329,211
2020-11-17	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−5,357 sh	$8.75	−$46.9K	339,211
2020-11-16	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−633 sh	$8.98	−$5,684.34	334,568
2020-11-16	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−633 sh	$8.98	−$5,684.34	344,568
2020-10-19	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−5,673 sh	$8.75	−$49.6K	335,201
2020-10-15	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−317 sh	$8.75	−$2,773.75	340,874
2020-09-15	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−5,990 sh	$10.39	−$62.2K	341,191
2020-08-17	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−5,990 sh	$12.59	−$75.4K	347,181
2020-07-15	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−5,990 sh	$11.85	−$71K	353,171
2020-06-15	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−5,990 sh	$8.75	−$52.4K	359,161
2020-06-11	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2020-05-15	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−5,990 sh	$9.22	−$55.2K	365,151
2020-04-15	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−24K sh	$8.75	−$210K	371,141
2019-08-16	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−22.7K sh	$10.00	−$227K	395,101
2019-08-15	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−2,300 sh	$10.00	−$23K	417,801
2019-06-11	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2018-06-14	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000
2017-08-14	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−3,282 sh	$22.00	−$72.2K	420,101
2017-07-25	Syros Pharmaceuticals, Inc.S Sale	Director	SSale	−3,282 sh	$22.09	−$72.5K	423,383
2017-06-08	Syros Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	11,000

Recent filings

Accepted (ET)
Aug 54
Young Richard A0001628280-26-053513
SEC(opens sec.gov)
Jun 124
Young Richard A0001628280-26-042862
SEC(opens sec.gov)
Sep 114
Young Richard A0001490283-25-000003
SEC(opens sec.gov)
Jun 274
Young Richard A0001736730-25-000060
SEC(opens sec.gov)
Oct 154
Young Richard A0001104659-24-108700
SEC(opens sec.gov)
Sep 184
Young Richard A0000950170-24-107862
SEC(opens sec.gov)
Jul 24
Young Richard A0000950170-24-080480
SEC(opens sec.gov)
Jun 214
Young Richard A0000950170-24-076262
SEC(opens sec.gov)
Jun 74
Young Richard A0000950170-24-070705
SEC(opens sec.gov)
Sep 194
Young Richard A0001209191-23-049978
SEC(opens sec.gov)
Jun 94
Young Richard A0000899243-23-015153
SEC(opens sec.gov)
Jun 54
Young Richard A0000899243-23-014449
SEC(opens sec.gov)
Jun 24
Young Richard A0001209191-23-033738
SEC(opens sec.gov)
May 34
Young Richard A0000899243-23-012077
SEC(opens sec.gov)
Apr 104
Young Richard A0000899243-23-011034
SEC(opens sec.gov)

Companies

Address

C/O CAMP4 THERAPEUTICS CORPORATION ONE KENDALL SQ., BLDG 1400 WEST, 3RD FL.

CAMBRIDGE, MA, 02139